Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction

NCT06953180 is registered in ClinicalTrials.gov with Asfendiyarov Kazakh National Medical University as lead sponsor.

NCT NCT06953180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06953180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction
Lead sponsor
Asfendiyarov Kazakh National Medical University
Phase
Observational
Overall status
Recruiting
Start date
March 3, 2025
Completion date
December 31, 2026
Enrollment
6,720 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases (cvd), chronic kidney diseases, chronic respiratory diseases, obesity (disorder), type 2 diabetes